Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. - Wikidata - awgldk - TriplyDB

Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.

Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.

http://www.wikidata.org/entity/Q35091964

about

Managing migraine by patient profile: role of frovatriptan A review of frovatriptan for the treatment of menstrual migraine Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response EFNS guideline on the drug treatment of migraine - report of an EFNS task force Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.Resolution of concentration-response differences in onset of effect between subcutaneous and oral sumatriptan.Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.Acute Migraine Treatment in Adults.CGRP receptor antagonists: an expanding drug class for acute migraine?Why pharmacokinetic differences among oral triptans have little clinical importance: a comment.A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine Systematic review and meta-analysis of traditional Chinese medicine in the treatment of migraines.Efficacy of frovatriptan as compared to other triptans in migraine with aura.Theoretical analysis of headache recurrence in patients administered triptans for migraine based on receptor occupancy.Clinical profile and practice experience of almotriptan.Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study What can be learned from the history of recurrence in migraine? A comment Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments.Review of frovatriptan in the treatment of migraine Frovatriptan review.Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.CGRP receptor antagonists: A new frontier of anti-migraine medications.Frovatriptan and rizatriptan economic EVAluation: the FREEVA study.Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan.Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies.Pharmacokinetic evaluation of frovatriptan.Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.What is the evidence for the use of corticosteroids in migraine?A model-based approach to treatment comparison in acute migraine.Prediction of headache response in migraine treatment.Quantifying the return of headache in triptan-treated migraineurs: an observational study.Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines.Pharmacokinetics of frovatriptan in adolescent migraineurs.Use of 5-HT1 agonists in pregnancy.The combination of naratriptan and prochlorperazine in migraine treatment.Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.

P2860

Q27002977-D7591D79-53C5-4375-A010-376BC97D6329 Q27025002-40C499DD-D2DE-4E7C-A862-EB1C88780269 Q28074159-43047C76-DB74-437F-9AF6-9A95F38F2331 Q28219436-D4CECF16-E8D0-4311-AA52-915D5493E9E0 Q33847333-39CA14D9-DF4B-42AE-B725-30A9FE4087FA Q33958060-10C18284-120E-45D1-B922-171C299E7DD3 Q33987764-C074EE1C-F224-408C-B44B-92545216D7FE Q34393819-CF46292E-6EC8-43E3-8995-EE5E94E81C6D Q34471863-EDE6C8D6-7B1D-4BC3-AC71-EE223EF2001D Q34637610-46DE5FE5-3A4A-433A-990E-172E70DB8848 Q34770884-9177911C-00E1-4BBB-AEA3-0A0F4D3E97A5 Q34786088-DFAF2736-9B85-481C-B09B-400F1F7E47BA Q34981791-3B961047-FC6F-4258-9D6A-50E784807B18 Q35015348-02BB5FD1-B81B-425F-BD55-8B44F0EC2484 Q35418862-77FE424F-2A74-4FF9-B67B-A0CC5713C052 Q35916053-8BC84079-BDB5-416F-8686-628A730CFBB4 Q35982145-AEA39EAE-3F77-43E5-8B28-ADB5B3D5B0EB Q35996223-76F28CAC-544A-41C8-B945-C0ABA1E8A7D9 Q36260684-E2DB3B25-5301-483E-9267-0A30019C4313 Q36335025-295B6E56-992D-4A19-81F8-4FCF44FFCD2E Q36367884-B7F02E79-E714-4BE6-908E-FABF0CDBA198 Q36662888-C315F795-D5D7-49F4-9731-27D8D4777859 Q36836794-851FD6F1-273E-4C51-8646-6C2A9C0EB6CB Q37000753-047B2787-23CB-4EAD-9257-1A379595746B Q37154795-C5155A92-1927-4101-AB6A-AA3CE72B7C17 Q37362635-FB1E33E3-92A2-42F4-A2F2-98EC80304E42 Q37427358-CD24C453-0E43-4541-8548-DB8C4DCC98E3 Q37685635-64757A6A-CF58-4EE8-B99F-5F135E952DF5 Q37870791-9326FEA2-CA9D-4F45-9D7D-46A6495F362A Q37935031-474B25CA-7651-4942-B9A6-AE75927FDAE2 Q38108485-B2331C4C-4A3D-489E-84CE-19BEDB6024EF Q38265392-2E7C7755-144C-4FA3-A280-5B835875D30D Q39344317-DA07C0B3-2A0C-4576-8ED6-8516504E1272 Q39353376-93E0FFD7-814D-4BB2-BBCA-17E367CCB63E Q42963776-672EDE86-8335-4242-A48E-A1B556AFCC30 Q43921835-F7828494-762D-4276-92D3-46D1E2381452 Q45040981-3CCE831A-EE26-4C62-A5EE-77162FDDE14C Q45112419-B7C09821-357E-491A-8E93-3E906DD81083 Q46543682-36DD2BAF-1761-4512-ADBC-0A9C45A7FB97 Q46783017-1DBC96E7-636A-4EB7-AD65-7E8101D9BD72

P2860

Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.

http://www.wikidata.org/entity/Q35091964

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Migraine headache recurrence: ...... inetic properties of triptans.

@ast

Migraine headache recurrence: ...... inetic properties of triptans.

@en

type

label

Migraine headache recurrence: ...... inetic properties of triptans.

@ast

Migraine headache recurrence: ...... inetic properties of triptans.

@en

prefLabel

Migraine headache recurrence: ...... inetic properties of triptans.

@ast

Migraine headache recurrence: ...... inetic properties of triptans.

@en

P1433

Q35091964-AFAEAF8B-89F0-4441-ABF8-E715036B0421

P1476

Q35091964-B03A4FB6-06CE-4F6E-80F4-A226F67D2CBE

P2093

Q35091964-0699EE5D-0B06-457E-965B-F81A19C61A6B

Q35091964-5D170332-3B50-4721-BB73-0F6EA3969114

Q35091964-75C2201B-7111-4878-A100-0F1A7CAF0BB7

P2860

Q35091964-0002894A-C5A5-49D1-AFBC-9D31EB185420

Q35091964-1E716D54-CD3A-443B-845E-D4D1E635E7C4

Q35091964-2B632328-0D74-4E9B-996E-E70CBE0C1BE3

Q35091964-2EB5EE97-B346-4884-8D02-E97CB8574E62

Q35091964-51935CB3-8674-42E5-8519-E85BFA51B4D7

Q35091964-5AAA90A1-B189-459D-BD58-5E643DB536AB

Q35091964-61B1FC76-7789-4972-85F5-EA1CC3866D64

Q35091964-747ED043-7F9A-454C-8DC8-73E05C9818A5

Q35091964-795B09CA-CC8E-4A12-BA6E-6EE17720A9E7

Q35091964-9C872DF6-37E2-48CD-9329-329D10967900

P304

Q35091964-E7B843F4-78F4-4509-97A4-0316F98CDDFB

P31

Q35091964-AB5D4541-F913-4ABA-9CB3-1AFAE2307BEF

P356

Q35091964-C4A13FA5-0744-49D7-A101-820C8A494E00

P433

Q35091964-E3AF5575-B2C2-4197-BFFD-0E5DB73FC110

P478

Q35091964-E7FFC2FA-E7F2-4B59-A5A4-19A4AF17C29D

P577

Q35091964-45A49BFB-9D86-44D6-98E8-A8EC4478F348

P698

Q35091964-A75114BA-B3CD-4B95-99B7-98F822BA8A26

P921

Q35091964-0AD57591-CF98-453A-A59C-B9210EC26739

Q35091964-53AAD3AF-277C-432E-9865-4DFAB3B40160

P356

J.1526-4610.2003.03073.X

P1433

P1476

Migraine headache recurrence: ...... inetic properties of triptans.

@en

P2093

Charlotte Keywood

http://www.w3.org/2001/XMLSchema#string

Gilles Géraud

http://www.w3.org/2001/XMLSchema#string

Jean Michel Senard

http://www.w3.org/2001/XMLSchema#string

P2860

Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Frovatriptan for the acute treatment of migraine: a dose-finding study.

Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine.

Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.

Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.

Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group.

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.

Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan.

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group.

P304

376-388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1526-4610.2003.03073.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12656709

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder